Statements (56)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Zymergen
gptkb:Aldevron |
| gptkbp:awards |
gptkb:World_Economic_Forum_Technology_Pioneer
Fast Company’s Most Creative People in Business MIT Technology Review’s 50 Smartest Companies |
| gptkbp:business_model |
gptkb:railway_line
platform model partnership model |
| gptkbp:ceo |
gptkb:Jason_Kelly
|
| gptkbp:collaborations |
various government agencies
various startups various non-profits various research institutions various academic institutions |
| gptkbp:employees |
over 400
|
| gptkbp:focus |
organism engineering
|
| gptkbp:founded |
gptkb:2014
|
| gptkbp:founder |
gptkb:Jason_Kelly
gptkb:Tom_Knight gptkb:Reshma_Shetty Austin Che |
| gptkbp:headquarters |
gptkb:Boston,_Massachusetts
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ginkgo Bio Works, Inc.
|
| gptkbp:industry |
gptkb:Company
|
| gptkbp:investment |
$425 million
|
| gptkbp:ipo |
gptkb:2021
|
| gptkbp:location |
gptkb:United_States
|
| gptkbp:market |
agriculture
healthcare industrial applications food and beverage environmental applications |
| gptkbp:mission |
to make biology easier to engineer
|
| gptkbp:notable_work |
Ginkgo's COVID-19 testing program
Ginkgo's work on pharmaceuticals Ginkgo's work on sustainable materials Ginkgo's work with the food industry Ginkgo's partnership with the U. S. Department of Defense |
| gptkbp:partnerships |
various pharmaceutical companies
|
| gptkbp:research |
agricultural biotechnology
biomanufacturing industrial biotechnology microbial production |
| gptkbp:services |
gptkb:item
genetic engineering |
| gptkbp:stock_exchange |
gptkb:NYSE
|
| gptkbp:subsidiary |
Ginkgo Bioworks Asia
Ginkgo Bioworks Australia Ginkgo Bioworks Canada Ginkgo Bioworks Europe |
| gptkbp:technology |
DNA synthesis
cell programming |
| gptkbp:website |
ginkgobioworks.com
|
| gptkbp:bfsParent |
gptkb:Ginkgo_Bioworks
|
| gptkbp:bfsLayer |
3
|